Encompass Health Corporation $EHC Stake Lessened by Arkadios Wealth Advisors

Arkadios Wealth Advisors cut its stake in Encompass Health Corporation (NYSE:EHC) by 5.0% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,780 shares of the company’s stock after selling 463 shares during the period. Arkadios Wealth Advisors’ holdings in Encompass Health were worth $1,077,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. Whalen Wealth Management Inc. bought a new position in shares of Encompass Health in the second quarter valued at approximately $644,000. Jennison Associates LLC lifted its stake in Encompass Health by 0.3% during the second quarter. Jennison Associates LLC now owns 793,237 shares of the company’s stock valued at $97,275,000 after purchasing an additional 2,128 shares during the last quarter. Y Intercept Hong Kong Ltd boosted its holdings in Encompass Health by 339.3% during the second quarter. Y Intercept Hong Kong Ltd now owns 21,891 shares of the company’s stock worth $2,684,000 after buying an additional 16,908 shares in the last quarter. Envestnet Asset Management Inc. boosted its holdings in Encompass Health by 26.6% during the second quarter. Envestnet Asset Management Inc. now owns 375,956 shares of the company’s stock worth $46,103,000 after buying an additional 79,095 shares in the last quarter. Finally, Nisa Investment Advisors LLC boosted its holdings in Encompass Health by 3.4% during the second quarter. Nisa Investment Advisors LLC now owns 16,422 shares of the company’s stock worth $2,014,000 after buying an additional 547 shares in the last quarter. 97.25% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on the stock. Barclays raised their target price on shares of Encompass Health from $141.00 to $150.00 and gave the stock an “overweight” rating in a report on Thursday. UBS Group raised their target price on shares of Encompass Health from $140.00 to $150.00 and gave the stock a “buy” rating in a report on Thursday, October 2nd. KeyCorp raised their target price on shares of Encompass Health from $135.00 to $140.00 and gave the stock an “overweight” rating in a report on Tuesday, September 16th. Bank of America raised their target price on shares of Encompass Health from $145.00 to $160.00 and gave the stock a “buy” rating in a report on Wednesday, September 10th. Finally, Zacks Research upgraded shares of Encompass Health from a “hold” rating to a “strong-buy” rating in a report on Tuesday, October 21st. Two equities research analysts have rated the stock with a Strong Buy rating and eight have given a Buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Buy” and an average target price of $142.86.

Insider Buying and Selling at Encompass Health

In other news, EVP Patrick William Tuer sold 1,020 shares of Encompass Health stock in a transaction dated Wednesday, August 27th. The shares were sold at an average price of $123.59, for a total transaction of $126,061.80. Following the sale, the executive vice president directly owned 18,846 shares in the company, valued at approximately $2,329,177.14. The trade was a 5.13% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 2.00% of the company’s stock.

Encompass Health Stock Down 2.5%

EHC stock opened at $113.86 on Friday. Encompass Health Corporation has a 12-month low of $87.85 and a 12-month high of $127.99. The company has a quick ratio of 1.06, a current ratio of 1.06 and a debt-to-equity ratio of 0.76. The company has a market cap of $11.47 billion, a price-to-earnings ratio of 21.52, a PEG ratio of 2.20 and a beta of 0.93. The company has a 50 day moving average of $124.22 and a two-hundred day moving average of $118.99.

Encompass Health (NYSE:EHC) last announced its earnings results on Wednesday, March 16th. The company reported $0.93 EPS for the quarter. The firm had revenue of $136.30 million for the quarter. Encompass Health had a net margin of 9.33% and a return on equity of 18.19%. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. On average, equities analysts anticipate that Encompass Health Corporation will post 4.8 earnings per share for the current fiscal year.

Encompass Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, January 15th. Stockholders of record on Friday, January 2nd will be given a dividend of $0.19 per share. This represents a $0.76 annualized dividend and a dividend yield of 0.7%. The ex-dividend date is Friday, January 2nd. Encompass Health’s payout ratio is 14.37%.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.